Willfact

Willfact is a human von Willebrand factor product designed for intravenous use, supporting hemostasis in bleeding disorders. This EU-sourced treatment is used to manage von Willebrand disease and related conditions. Ideal for patients requiring reliable coagulation support.

Willfact is used to treat and prevent bleeding episodes in patients with von Willebrand disease, a condition where blood does not clot properly. It may also be used before medical procedures to reduce bleeding risk in affected individuals. This product replaces missing or low von Willebrand factor in the bloodstream.

Willfact works by temporarily increasing levels of von Willebrand factor in the blood, which helps blood to clot more effectively. Users may notice reduced bleeding or faster clotting during treatment. Effects vary based on individual condition and dosage.

Store Willfact as directed, typically refrigerated but protected from freezing. Avoid shaking the vial to prevent damage to the product. Always check the expiration date before use and ensure proper handling to maintain sterility. Consult healthcare provider for guidance on administration.

Willfact may interact with other medications affecting blood clotting, such as anticoagulants or antiplatelet drugs. Alcohol and certain herbal supplements could also influence its effects. Always inform your healthcare provider about all medications and supplements you are taking.